161 related articles for article (PubMed ID: 8094999)
1. Induction of antitumor L3T4-positive T cells by OK-432 at tumor sites in mice.
Moriya Y; Sato H; Ito K; Saito M; Yoshida T; Ishida N
Cancer Immunol Immunother; 1993; 36(4):245-50. PubMed ID: 8094999
[TBL] [Abstract][Full Text] [Related]
2. Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.
Saito M; Ichimura O; Kataoka M; Moriya Y; Ueno K; Sugawara Y; Nanjo M; Ishida N
Cancer Immunol Immunother; 1986; 22(3):161-8. PubMed ID: 2425968
[TBL] [Abstract][Full Text] [Related]
3. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].
Ishida N; Saito M; Nanjo M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2681-90. PubMed ID: 6508321
[TBL] [Abstract][Full Text] [Related]
4. Analysis of antitumor effects of OK-432 against syngeneic mouse fibrosarcoma: combination effect of OK-432 and recombinant lymphokines.
Nanjo M; Moriya Y; Hashimoto S; Kataoka M; Saito M; Yoshida T; Ishida N
Int J Immunopharmacol; 1991; 13(2-3):205-15. PubMed ID: 1906439
[TBL] [Abstract][Full Text] [Related]
5. The changing pattern of the splenic lymphocyte subsets in tumor-bearing mice after oral treatment with OK-432.
Akamatsu Y; Fuchimoto S; Orita K
Jpn J Cancer Res; 1992 Jun; 83(6):656-60. PubMed ID: 1353756
[TBL] [Abstract][Full Text] [Related]
6. Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice.
Saito M; Nanjo M; Kataoka M; Moriya Y; Sugawara Y; Yoshida T; Ishida N
Cancer Res; 1988 Aug; 48(15):4163-7. PubMed ID: 3390809
[TBL] [Abstract][Full Text] [Related]
7. Combination chemo-immunotherapy of murine solid tumor with OK-432, G-CSF, IL-2, and chemotherapeutics.
Iida S; Matsuoka S; Kudo C; Moriya Y; Yoshida T; Saito M
Int J Immunopharmacol; 1995 Dec; 17(12):973-80. PubMed ID: 8964656
[TBL] [Abstract][Full Text] [Related]
8. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2546-55. PubMed ID: 2614190
[TBL] [Abstract][Full Text] [Related]
9. [Effect of biological response modifiers on a spontaneous murine renal cell carcinoma regression of metastases caused by the streptococcal preparation OK-432].
Tanji S
Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):716-25. PubMed ID: 1875566
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.
Okamoto M; Ohe G; Furuichi S; Nishikawa H; Oshikawa T; Tano T; Ahmed SU; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
Anticancer Res; 2002; 22(6A):3229-39. PubMed ID: 12530069
[TBL] [Abstract][Full Text] [Related]
11. [Combined effect of intraperitoneally administered OK-432 and recombinant interleukin (rIL-2) against mouse tumors].
Fujioka T; Shiraishi M; Tanji S; Koike H; Kumagai K; Kubo T; Ohhori T
Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):948-56. PubMed ID: 2789265
[TBL] [Abstract][Full Text] [Related]
12. Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor.
Weiskirch LM; Barker E; Mokyr MB
Cancer Immunol Immunother; 1990; 31(3):129-38. PubMed ID: 2337902
[TBL] [Abstract][Full Text] [Related]
13. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
Saito M; Aonuma E; Noda T; Nakadate I; Nanjo M; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
[TBL] [Abstract][Full Text] [Related]
14. Successful adoptive immunotherapy with OK432-inducible activated natural killer cells in tumor-bearing mice.
Yamaue H; Tanimura H; Iwahashi M; Tsunoda T; Tani M; Inoue M
Biotherapy; 1990; 2(1):51-61. PubMed ID: 2400628
[TBL] [Abstract][Full Text] [Related]
15. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
Fuyama S; Komatsu H; Arai S
Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379
[TBL] [Abstract][Full Text] [Related]
16. Adoptive immunotherapy in tumor-bearing mice with OK-432-induced killer cells.
Ujiie T
Jpn J Exp Med; 1988 Apr; 58(2):109-14. PubMed ID: 3261814
[TBL] [Abstract][Full Text] [Related]
17. Activated macrophages are responsible for the tumor-inhibitory effect in mice receiving intravenous injection of OK-432.
Saito M; Nanjo M; Aonuma E; Noda T; Nakadate I; Ebina T; Ishida N
Int J Cancer; 1984 Feb; 33(2):271-6. PubMed ID: 6420351
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). I. Sequential effector mechanisms following a single OK-432 injection in F344 rats leading to the rejection of syngeneic MADB106 tumor cells.
Fukui H; Reynolds CW
J Natl Cancer Inst; 1987 Nov; 79(5):1011-7. PubMed ID: 3479632
[TBL] [Abstract][Full Text] [Related]
19. Prevention of lymph node metastases by adoptive transfer of CD4+ T lymphocytes admixed with irradiated tumor cells.
Yoshida K; Tachibana T
Cancer Immunol Immunother; 1993 May; 36(5):323-30. PubMed ID: 8097428
[TBL] [Abstract][Full Text] [Related]
20. [Effect of combined immunotherapy using two different BRMs; OK-432 and IL-2-cultured lymphocytes].
Kan N; Hori T; Ohgaki K; Inamoto T; Kodama H; Tobe T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1298-306. PubMed ID: 3488027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
